Cargando…
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway
BACKGROUND: ALX4 is a paired-like homedomain transcription factor mainly expressed in the mesenchymal compartment of variety of developing tissues, but its functions, regulation mechanisms and clinical values in breast cancer remains unclear. METHODS: The expression of ALX4 in breast cancer cell lin...
Autores principales: | Yang, Juntang, Han, Fei, Liu, Wenbin, Chen, Hongqiang, Hao, Xianglin, Jiang, Xiao, Yin, Li, Huang, Yongsheng, Cao, Jia, Zhang, Huidong, Liu, Jinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706407/ https://www.ncbi.nlm.nih.gov/pubmed/29183346 http://dx.doi.org/10.1186/s13046-017-0643-9 |
Ejemplares similares
-
LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-catenin
por: Yang, Juntang, et al.
Publicado: (2017) -
WNK regulates Wnt signalling and β-Catenin levels by interfering with the interaction between β-Catenin and GID
por: Sato, Atsushi, et al.
Publicado: (2020) -
Epigenetic Regulation of Sox30 Is Associated with Testis Development in Mice
por: Han, Fei, et al.
Publicado: (2014) -
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus
por: Granno, Simone, et al.
Publicado: (2019) -
Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
por: Sharma, Ankita, et al.
Publicado: (2021)